English
简体中文
Total: £ 56.28
Published Date: 2025-11-19 | Pages: 135 | Tables: 137 | Medical Care
The global market for Medical Isotopes was estimated to be worth US$ 836 million in 2024 and is forecast to a readjusted size of US$ 1074 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a "cold" process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.
North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.
This report aims to provide a comprehensive presentation of the global market for Medical Isotopes, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Isotopes by region & country, by Type, and by Application.
The Medical Isotopes market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Isotopes.
Market Segmentation
By Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science
Segment by Type
Stable Isotopes
Radioisotopes
Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Isotopes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Isotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Isotopes in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Medical Isotopes Product Introduction
1.2 Global Medical Isotopes Market Size Forecast (2020-2031)
1.3 Medical Isotopes Market Trends & Drivers
1.3.1 Medical Isotopes Industry Trends
1.3.2 Medical Isotopes Market Drivers & Opportunity
1.3.3 Medical Isotopes Market Challenges
1.3.4 Medical Isotopes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Isotopes Players Revenue Ranking (2024)
2.2 Global Medical Isotopes Revenue by Company (2020-2025)
2.3 Key Companies Medical Isotopes Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Isotopes Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Isotopes
2.6 Medical Isotopes Market Competitive Analysis
2.6.1 Medical Isotopes Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Medical Isotopes Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Isotopes as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stable Isotopes
3.1.2 Radioisotopes
3.2 Global Medical Isotopes Sales Value by Type
3.2.1 Global Medical Isotopes Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Medical Isotopes Sales Value, by Type (2020-2031)
3.2.3 Global Medical Isotopes Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Nuclear Therapy
4.1.2 Equipment Radioactive Source
4.1.3 Diagnosis
4.2 Global Medical Isotopes Sales Value by Application
4.2.1 Global Medical Isotopes Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Medical Isotopes Sales Value, by Application (2020-2031)
4.2.3 Global Medical Isotopes Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Medical Isotopes Sales Value by Region
5.1.1 Global Medical Isotopes Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Medical Isotopes Sales Value by Region (2020-2025)
5.1.3 Global Medical Isotopes Sales Value by Region (2026-2031)
5.1.4 Global Medical Isotopes Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Medical Isotopes Sales Value, 2020-2031
5.2.2 North America Medical Isotopes Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Medical Isotopes Sales Value, 2020-2031
5.3.2 Europe Medical Isotopes Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Isotopes Sales Value, 2020-2031
5.4.2 Asia Pacific Medical Isotopes Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Medical Isotopes Sales Value, 2020-2031
5.5.2 South America Medical Isotopes Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Isotopes Sales Value, 2020-2031
5.6.2 Middle East & Africa Medical Isotopes Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Isotopes Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Medical Isotopes Sales Value, 2020-2031
6.3 United States
6.3.1 United States Medical Isotopes Sales Value, 2020-2031
6.3.2 United States Medical Isotopes Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Medical Isotopes Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Medical Isotopes Sales Value, 2020-2031
6.4.2 Europe Medical Isotopes Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Medical Isotopes Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Medical Isotopes Sales Value, 2020-2031
6.5.2 China Medical Isotopes Sales Value by Type (%), 2024 VS 2031
6.5.3 China Medical Isotopes Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Medical Isotopes Sales Value, 2020-2031
6.6.2 Japan Medical Isotopes Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Medical Isotopes Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Medical Isotopes Sales Value, 2020-2031
6.7.2 South Korea Medical Isotopes Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Medical Isotopes Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Isotopes Sales Value, 2020-2031
6.8.2 Southeast Asia Medical Isotopes Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Medical Isotopes Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Medical Isotopes Sales Value, 2020-2031
6.9.2 India Medical Isotopes Sales Value by Type (%), 2024 VS 2031
6.9.3 India Medical Isotopes Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 NRG
7.1.1 NRG Profile
7.1.2 NRG Main Business
7.1.3 NRG Medical Isotopes Products, Services and Solutions
7.1.4 NRG Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.1.5 NRG Recent Developments
7.2 NTP Radioisotopes
7.2.1 NTP Radioisotopes Profile
7.2.2 NTP Radioisotopes Main Business
7.2.3 NTP Radioisotopes Medical Isotopes Products, Services and Solutions
7.2.4 NTP Radioisotopes Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.2.5 NTP Radioisotopes Recent Developments
7.3 JSC Isotope
7.3.1 JSC Isotope Profile
7.3.2 JSC Isotope Main Business
7.3.3 JSC Isotope Medical Isotopes Products, Services and Solutions
7.3.4 JSC Isotope Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.3.5 JSC Isotope Recent Developments
7.4 ANSTO
7.4.1 ANSTO Profile
7.4.2 ANSTO Main Business
7.4.3 ANSTO Medical Isotopes Products, Services and Solutions
7.4.4 ANSTO Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.4.5 ANSTO Recent Developments
7.5 IRE
7.5.1 IRE Profile
7.5.2 IRE Main Business
7.5.3 IRE Medical Isotopes Products, Services and Solutions
7.5.4 IRE Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.5.5 IRE Recent Developments
7.6 Nordion
7.6.1 Nordion Profile
7.6.2 Nordion Main Business
7.6.3 Nordion Medical Isotopes Products, Services and Solutions
7.6.4 Nordion Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.6.5 Nordion Recent Developments
7.7 Curium Pharma
7.7.1 Curium Pharma Profile
7.7.2 Curium Pharma Main Business
7.7.3 Curium Pharma Medical Isotopes Products, Services and Solutions
7.7.4 Curium Pharma Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.7.5 Curium Pharma Recent Developments
7.8 Cambridge Isotope Laboratories
7.8.1 Cambridge Isotope Laboratories Profile
7.8.2 Cambridge Isotope Laboratories Main Business
7.8.3 Cambridge Isotope Laboratories Medical Isotopes Products, Services and Solutions
7.8.4 Cambridge Isotope Laboratories Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.8.5 Cambridge Isotope Laboratories Recent Developments
7.9 Eckert & Ziegler Strahlen
7.9.1 Eckert & Ziegler Strahlen Profile
7.9.2 Eckert & Ziegler Strahlen Main Business
7.9.3 Eckert & Ziegler Strahlen Medical Isotopes Products, Services and Solutions
7.9.4 Eckert & Ziegler Strahlen Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.9.5 Eckert & Ziegler Strahlen Recent Developments
7.10 Polatom
7.10.1 Polatom Profile
7.10.2 Polatom Main Business
7.10.3 Polatom Medical Isotopes Products, Services and Solutions
7.10.4 Polatom Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.10.5 Polatom Recent Developments
7.11 Center of Molecular Research
7.11.1 Center of Molecular Research Profile
7.11.2 Center of Molecular Research Main Business
7.11.3 Center of Molecular Research Medical Isotopes Products, Services and Solutions
7.11.4 Center of Molecular Research Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.11.5 Center of Molecular Research Recent Developments
7.12 China National Nuclear Corporation
7.12.1 China National Nuclear Corporation Profile
7.12.2 China National Nuclear Corporation Main Business
7.12.3 China National Nuclear Corporation Medical Isotopes Products, Services and Solutions
7.12.4 China National Nuclear Corporation Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.12.5 China National Nuclear Corporation Recent Developments
7.13 Urenco
7.13.1 Urenco Profile
7.13.2 Urenco Main Business
7.13.3 Urenco Medical Isotopes Products, Services and Solutions
7.13.4 Urenco Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.13.5 Urenco Recent Developments
7.14 LANL
7.14.1 LANL Profile
7.14.2 LANL Main Business
7.14.3 LANL Medical Isotopes Products, Services and Solutions
7.14.4 LANL Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.14.5 LANL Recent Developments
7.15 Shanghai Engineering Research Center
7.15.1 Shanghai Engineering Research Center Profile
7.15.2 Shanghai Engineering Research Center Main Business
7.15.3 Shanghai Engineering Research Center Medical Isotopes Products, Services and Solutions
7.15.4 Shanghai Engineering Research Center Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.15.5 Shanghai Engineering Research Center Recent Developments
7.16 IDB Holland
7.16.1 IDB Holland Profile
7.16.2 IDB Holland Main Business
7.16.3 IDB Holland Medical Isotopes Products, Services and Solutions
7.16.4 IDB Holland Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.16.5 IDB Holland Recent Developments
7.17 NHTC
7.17.1 NHTC Profile
7.17.2 NHTC Main Business
7.17.3 NHTC Medical Isotopes Products, Services and Solutions
7.17.4 NHTC Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.17.5 NHTC Recent Developments
7.18 Linde
7.18.1 Linde Profile
7.18.2 Linde Main Business
7.18.3 Linde Medical Isotopes Products, Services and Solutions
7.18.4 Linde Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.18.5 Linde Recent Developments
7.19 ORNL
7.19.1 ORNL Profile
7.19.2 ORNL Main Business
7.19.3 ORNL Medical Isotopes Products, Services and Solutions
7.19.4 ORNL Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.19.5 ORNL Recent Developments
7.20 SI Science
7.20.1 SI Science Profile
7.20.2 SI Science Main Business
7.20.3 SI Science Medical Isotopes Products, Services and Solutions
7.20.4 SI Science Medical Isotopes Revenue (US$ Million) & (2020-2025)
7.20.5 SI Science Recent Developments
8 Industry Chain Analysis
8.1 Medical Isotopes Industrial Chain
8.2 Medical Isotopes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Isotopes Sales Model
8.5.2 Sales Channel
8.5.3 Medical Isotopes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Medical Isotopes Market Trends
Table 2. Medical Isotopes Market Drivers & Opportunity
Table 3. Medical Isotopes Market Challenges
Table 4. Medical Isotopes Market Restraints
Table 5. Global Medical Isotopes Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Medical Isotopes Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Medical Isotopes Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Medical Isotopes Product Type
Table 9. Key Companies Time to Begin Mass Production of Medical Isotopes
Table 10. Global Medical Isotopes Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Isotopes as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Medical Isotopes Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Medical Isotopes Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Medical Isotopes Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Medical Isotopes Sales Market Share in Value by Type (2020-2025)
Table 17. Global Medical Isotopes Sales Market Share in Value by Type (2026-2031)
Table 18. Global Medical Isotopes Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Medical Isotopes Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Medical Isotopes Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Medical Isotopes Sales Market Share in Value by Application (2020-2025)
Table 22. Global Medical Isotopes Sales Market Share in Value by Application (2026-2031)
Table 23. Global Medical Isotopes Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Medical Isotopes Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Medical Isotopes Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Medical Isotopes Sales Value by Region (2020-2025) & (%)
Table 27. Global Medical Isotopes Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Medical Isotopes Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Medical Isotopes Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Medical Isotopes Sales Value, (2026-2031) & (US$ Million)
Table 31. NRG Basic Information List
Table 32. NRG Description and Business Overview
Table 33. NRG Medical Isotopes Products, Services and Solutions
Table 34. Revenue (US$ Million) in Medical Isotopes Business of NRG (2020-2025)
Table 35. NRG Recent Developments
Table 36. NTP Radioisotopes Basic Information List
Table 37. NTP Radioisotopes Description and Business Overview
Table 38. NTP Radioisotopes Medical Isotopes Products, Services and Solutions
Table 39. Revenue (US$ Million) in Medical Isotopes Business of NTP Radioisotopes (2020-2025)
Table 40. NTP Radioisotopes Recent Developments
Table 41. JSC Isotope Basic Information List
Table 42. JSC Isotope Description and Business Overview
Table 43. JSC Isotope Medical Isotopes Products, Services and Solutions
Table 44. Revenue (US$ Million) in Medical Isotopes Business of JSC Isotope (2020-2025)
Table 45. JSC Isotope Recent Developments
Table 46. ANSTO Basic Information List
Table 47. ANSTO Description and Business Overview
Table 48. ANSTO Medical Isotopes Products, Services and Solutions
Table 49. Revenue (US$ Million) in Medical Isotopes Business of ANSTO (2020-2025)
Table 50. ANSTO Recent Developments
Table 51. IRE Basic Information List
Table 52. IRE Description and Business Overview
Table 53. IRE Medical Isotopes Products, Services and Solutions
Table 54. Revenue (US$ Million) in Medical Isotopes Business of IRE (2020-2025)
Table 55. IRE Recent Developments
Table 56. Nordion Basic Information List
Table 57. Nordion Description and Business Overview
Table 58. Nordion Medical Isotopes Products, Services and Solutions
Table 59. Revenue (US$ Million) in Medical Isotopes Business of Nordion (2020-2025)
Table 60. Nordion Recent Developments
Table 61. Curium Pharma Basic Information List
Table 62. Curium Pharma Description and Business Overview
Table 63. Curium Pharma Medical Isotopes Products, Services and Solutions
Table 64. Revenue (US$ Million) in Medical Isotopes Business of Curium Pharma (2020-2025)
Table 65. Curium Pharma Recent Developments
Table 66. Cambridge Isotope Laboratories Basic Information List
Table 67. Cambridge Isotope Laboratories Description and Business Overview
Table 68. Cambridge Isotope Laboratories Medical Isotopes Products, Services and Solutions
Table 69. Revenue (US$ Million) in Medical Isotopes Business of Cambridge Isotope Laboratories (2020-2025)
Table 70. Cambridge Isotope Laboratories Recent Developments
Table 71. Eckert & Ziegler Strahlen Basic Information List
Table 72. Eckert & Ziegler Strahlen Description and Business Overview
Table 73. Eckert & Ziegler Strahlen Medical Isotopes Products, Services and Solutions
Table 74. Revenue (US$ Million) in Medical Isotopes Business of Eckert & Ziegler Strahlen (2020-2025)
Table 75. Eckert & Ziegler Strahlen Recent Developments
Table 76. Polatom Basic Information List
Table 77. Polatom Description and Business Overview
Table 78. Polatom Medical Isotopes Products, Services and Solutions
Table 79. Revenue (US$ Million) in Medical Isotopes Business of Polatom (2020-2025)
Table 80. Polatom Recent Developments
Table 81. Center of Molecular Research Basic Information List
Table 82. Center of Molecular Research Description and Business Overview
Table 83. Center of Molecular Research Medical Isotopes Products, Services and Solutions
Table 84. Revenue (US$ Million) in Medical Isotopes Business of Center of Molecular Research (2020-2025)
Table 85. Center of Molecular Research Recent Developments
Table 86. China National Nuclear Corporation Basic Information List
Table 87. China National Nuclear Corporation Description and Business Overview
Table 88. China National Nuclear Corporation Medical Isotopes Products, Services and Solutions
Table 89. Revenue (US$ Million) in Medical Isotopes Business of China National Nuclear Corporation (2020-2025)
Table 90. China National Nuclear Corporation Recent Developments
Table 91. Urenco Basic Information List
Table 92. Urenco Description and Business Overview
Table 93. Urenco Medical Isotopes Products, Services and Solutions
Table 94. Revenue (US$ Million) in Medical Isotopes Business of Urenco (2020-2025)
Table 95. Urenco Recent Developments
Table 96. LANL Basic Information List
Table 97. LANL Description and Business Overview
Table 98. LANL Medical Isotopes Products, Services and Solutions
Table 99. Revenue (US$ Million) in Medical Isotopes Business of LANL (2020-2025)
Table 100. LANL Recent Developments
Table 101. Shanghai Engineering Research Center Basic Information List
Table 102. Shanghai Engineering Research Center Description and Business Overview
Table 103. Shanghai Engineering Research Center Medical Isotopes Products, Services and Solutions
Table 104. Revenue (US$ Million) in Medical Isotopes Business of Shanghai Engineering Research Center (2020-2025)
Table 105. Shanghai Engineering Research Center Recent Developments
Table 106. IDB Holland Basic Information List
Table 107. IDB Holland Description and Business Overview
Table 108. IDB Holland Medical Isotopes Products, Services and Solutions
Table 109. Revenue (US$ Million) in Medical Isotopes Business of IDB Holland (2020-2025)
Table 110. IDB Holland Recent Developments
Table 111. NHTC Basic Information List
Table 112. NHTC Description and Business Overview
Table 113. NHTC Medical Isotopes Products, Services and Solutions
Table 114. Revenue (US$ Million) in Medical Isotopes Business of NHTC (2020-2025)
Table 115. NHTC Recent Developments
Table 116. Linde Basic Information List
Table 117. Linde Description and Business Overview
Table 118. Linde Medical Isotopes Products, Services and Solutions
Table 119. Revenue (US$ Million) in Medical Isotopes Business of Linde (2020-2025)
Table 120. Linde Recent Developments
Table 121. ORNL Basic Information List
Table 122. ORNL Description and Business Overview
Table 123. ORNL Medical Isotopes Products, Services and Solutions
Table 124. Revenue (US$ Million) in Medical Isotopes Business of ORNL (2020-2025)
Table 125. ORNL Recent Developments
Table 126. SI Science Basic Information List
Table 127. SI Science Description and Business Overview
Table 128. SI Science Medical Isotopes Products, Services and Solutions
Table 129. Revenue (US$ Million) in Medical Isotopes Business of SI Science (2020-2025)
Table 130. SI Science Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Medical Isotopes Downstream Customers
Table 134. Medical Isotopes Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Medical Isotopes Product Picture
Figure 2. Global Medical Isotopes Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Medical Isotopes Sales Value (2020-2031) & (US$ Million)
Figure 4. Medical Isotopes Report Years Considered
Figure 5. Global Medical Isotopes Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Medical Isotopes Revenue in 2024
Figure 7. Medical Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Stable Isotopes Picture
Figure 9. Radioisotopes Picture
Figure 10. Global Medical Isotopes Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Medical Isotopes Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Nuclear Therapy
Figure 13. Product Picture of Equipment Radioactive Source
Figure 14. Product Picture of Diagnosis
Figure 15. Global Medical Isotopes Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Medical Isotopes Sales Value Market Share by Application, 2024 & 2031
Figure 17. North America Medical Isotopes Sales Value (2020-2031) & (US$ Million)
Figure 18. North America Medical Isotopes Sales Value by Country (%), 2024 VS 2031
Figure 19. Europe Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 20. Europe Medical Isotopes Sales Value by Country (%), 2024 VS 2031
Figure 21. Asia Pacific Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 22. Asia Pacific Medical Isotopes Sales Value by Region (%), 2024 VS 2031
Figure 23. South America Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 24. South America Medical Isotopes Sales Value by Country (%), 2024 VS 2031
Figure 25. Middle East & Africa Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 26. Middle East & Africa Medical Isotopes Sales Value by Country (%), 2024 VS 2031
Figure 27. Key Countries/Regions Medical Isotopes Sales Value (%), (2020-2031)
Figure 28. United States Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 29. United States Medical Isotopes Sales Value by Type (%), 2024 VS 2031
Figure 30. United States Medical Isotopes Sales Value by Application (%), 2024 VS 2031
Figure 31. Europe Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Medical Isotopes Sales Value by Type (%), 2024 VS 2031
Figure 33. Europe Medical Isotopes Sales Value by Application (%), 2024 VS 2031
Figure 34. China Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 35. China Medical Isotopes Sales Value by Type (%), 2024 VS 2031
Figure 36. China Medical Isotopes Sales Value by Application (%), 2024 VS 2031
Figure 37. Japan Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 38. Japan Medical Isotopes Sales Value by Type (%), 2024 VS 2031
Figure 39. Japan Medical Isotopes Sales Value by Application (%), 2024 VS 2031
Figure 40. South Korea Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 41. South Korea Medical Isotopes Sales Value by Type (%), 2024 VS 2031
Figure 42. South Korea Medical Isotopes Sales Value by Application (%), 2024 VS 2031
Figure 43. Southeast Asia Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Medical Isotopes Sales Value by Type (%), 2024 VS 2031
Figure 45. Southeast Asia Medical Isotopes Sales Value by Application (%), 2024 VS 2031
Figure 46. India Medical Isotopes Sales Value, (2020-2031) & (US$ Million)
Figure 47. India Medical Isotopes Sales Value by Type (%), 2024 VS 2031
Figure 48. India Medical Isotopes Sales Value by Application (%), 2024 VS 2031
Figure 49. Medical Isotopes Industrial Chain
Figure 50. Medical Isotopes Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
